General Hospital of Thessalonikis "G. Papanikolaou"
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lampaki, Sofia
GALAXIES Lung-301, NCT06472076: A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Recruiting
3
1000
Europe, Canada, Japan, RoW
Dostarlimab, Belrestotug, Pembrolizumab, Placebo
GlaxoSmithKline, iTeos Therapeutics
Lung Cancer, Non-Small Cell
09/28
09/29
SNF-CLIMEDIN, NCT05372081: Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer

Recruiting
N/A
200
Europe
Digital platform
Hellenic Cooperative Oncology Group, Stavros Niarchos Foundation, Care Across Ltd
Non-Small Cell Carcinoma of Lung, TNM Stage 4
09/24
03/25

Download Options